SCHEMBL9940914

SCHEMBL9940914

NC(=O)c1ccc(-c2cnc3c(NCC4CCCO4)nccn23)cc1C1CC1

nearest known ligand 0.51

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TTK P33981 16/20 0.51
MAPKAPK5 Q8IW41 2/20 0.45
AURKA O14965 1/20 0.43
RPS6KB1 P23443 1/20 0.43
HSP90AA1 P07900 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9941201 0.85 TTK (0.54) TTKMAPKAPK5
SCHEMBL9940274 0.84 TTK (0.55) TTKAURKARPS6KB1HSP90AA1
SCHEMBL9942386 0.83 TTK (0.49) TTKAURKARPS6KB1HSP90AA1
SCHEMBL9940705 0.83 TTK (0.72) TTK
SCHEMBL9941299 0.83 TTK (0.61) TTK
SCHEMBL9941302 0.83 TTK (0.43) TTKAURKARPS6KB1HSP90AA1
SCHEMBL9940707 0.82 TTK (0.45) TTKAURKARPS6KB1HSP90AA1
SCHEMBL9940982 0.82 MAPKAPK5 (0.51) TTKMAPKAPK5
SCHEMBL15375677 0.82 TTK (0.60) TTK
SCHEMBL9942193 0.82 TTK (0.52) TTKAURKARPS6KB1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651948-A1 IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT HYPERPROLIFERATIVE DISORDERS Bayer Intellectual Property GmbH (DE) 2013-10-23 EP claimed
WO-2012080229-A1 IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT HYPERPROLIFERATIVE DISORDERS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-06-21 WO claimed